Cargando…
X-change symposium: status and future of modern radiation oncology—from technology to biology
Future radiation oncology encompasses a broad spectrum of topics ranging from modern clinical trial design to treatment and imaging technology and biology. In more detail, the application of hybrid MRI devices in modern image-guided radiotherapy; the emerging field of radiomics; the role of molecula...
Autores principales: | Corradini, Stefanie, Niyazi, Maximilian, Verellen, Dirk, Valentini, Vincenzo, Walsh, Seán, Grosu, Anca-L., Lauber, Kirsten, Giaccia, Amato, Unger, Kristian, Debus, Jürgen, Pieters, Bradley R., Guckenberger, Matthias, Senan, Suresh, Budach, Wilfried, Rad, Roland, Mayerle, Julia, Belka, Claus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863262/ https://www.ncbi.nlm.nih.gov/pubmed/33541387 http://dx.doi.org/10.1186/s13014-021-01758-w |
Ejemplares similares
-
First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments
por: Combs, Stephanie E., et al.
Publicado: (2020) -
Radiotherapy and "new" drugs-new side effects?
por: Niyazi, Maximilian, et al.
Publicado: (2011) -
Combined treatment with lexatumumab and irradiation leads to strongly increased long term tumour control under normoxic and hypoxic conditions
por: Marini, Patrizia, et al.
Publicado: (2009) -
Dose-volumetric parameters and prediction of severe acute esophagitis in patients with locally-advanced non small-cell lung cancer treated with neoadjuvant concurrent hyperfractionated-accelerated chemoradiotherapy
por: Manapov, Farkhad, et al.
Publicado: (2013) -
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clinical trial (MASPAC)
por: Pavic, M., et al.
Publicado: (2022)